ROCO
6543
Market cap31mUSD
Oct 08, Last price
17.75TWD
1D
0.00%
1Q
-1.39%
IPO
-6.08%
Name
Perfect Medical Industry Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Perfect Medical Industry Co., Ltd. is a Taiwanese enterprise specializing in the manufacturing and global distribution of a diverse range of health and medical supplies. Their extensive product portfolio encompasses critical medical consumables, including specialized tubing and needle sets for procedures like hemodialysis and A.V. fistula, as well as various huber and winged needle sets, blood transfusion and safety infusion sets, safety extension sets, I.V. locks, disposable syringes, and medical face masks. These offerings are marketed under the 'PF' brand, reaching a broad international customer base across Asia, Africa, Europe, and South America. Established in 1989, the company maintains its headquarters in Changhua, Taiwan.
Key people
Guoji Xu
Chairman of the Board · since 2023
Yatong Ye
Chief Financial Officer, Head of Finance & Accounting, Corporate Governance Officer · since 2025
Hongren Chen
General Manager · since 2020
Minsong Lai
Chief Information Security Officer · since 2025
Bozhen Chen
Director · since 2023
Longhu Huang
Director · since 2024
Zhengguo Zhuang
Director · since 2020
Yihui Du
Independent Director · since 2025
Yuxun Huang
Independent Director · since 2022
Jiahui Lai
Independent Director · since 2023
Kangting Lin
Independent Director · since 2025
Qiaoyun Lu
Independent Director · since 2025
Mingzhang Weng
Independent Director · since 2025
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||